Vai al contenuto principale
Ms Amrita Mahal
Punteggio di affidabilità 8/100

Ms Amrita Mahal

Speech And Language Therapy · United Kingdom

👤 2 anni di esperienza

6,779+ Patients seen
2 Years in practice
11 Publications
1 Languages spoken

Informazioni

Ms Amrita Mahal is an Advanced Speech & Language Therapist with over 18 years of clinical postgraduate experience, recognised as a highly skilled specialist in her field. As an integral member of Schoen Clinic Chelsea's multidisciplinary team, she plays a key role in the diagnosis of neurodevelopmental conditions such as Autism Spectrum Disorder and supports individuals across a broad range of communication, voice, and swallowing impairments and disorders.
Her expertise spans both paediatric and adult speech, language, and communication therapy, with a particular focus on the advanced management of complex swallowing disorders (dysphagia). Dr Mahal’s work addresses a wide array of conditions, including traumatic brain injuries, stroke recovery, head and neck cancers, as well as neurodevelopmental and progressive neurological conditions like Parkinson’s Disease and Functional Neurological Disorders.
A specialist in advanced dysphagia management, she provides evidence-based assessments and treatments such as clinical bedside swallow evaluations and functional swallowing rehabilitation using techniques like the McNeil Dysphagia Therapy Program and IQoro therapy. Her deep understanding of the neurophysiology of swallowing ensures comprehensive support for individuals with eating and drinking difficulties.
In addition, Dr Mahal is an advanced practitioner in managing voice disorders. She offers specialised voice therapy, including certified training in the Lee Silverman Voice Treatment (LSVT) program, and utilises techniques such as laryngeal manipulation and myofascial release therapy to relieve tension and improve vocal function. She supports professional voice users experiencing voice changes or loss and provides expert care for chronic cough and voice impairment related to acid reflux or respiratory conditions. Moreover, she offers Trans Voice and Communication Therapy to help individuals in the transgender community achieve authentic vocal expression.

“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”

— Ms Amrita Mahal

Istruzione e formazione

  1. 2014–2020 MD · Medicine and Surgery
    Universidad de Navarra (GB)
  2. 2020–2024 Residency · Speech And Language Therapy
    Universidad de Navarra (GB)

Carriera e incarichi

  1. 2024-09–2025-08 Junior consultant
    Universidad de Navarra Teaching Hospital — Speech And Language Therapy

Licenze e assicurazione

Licenze mediche

GB — Organización Médica Colegial de España (OMC)
#GB-802839 active · expires 2028-12-31

Certificazioni di specializzazione

European Board of Speech And Language Therapy
#EB-91DE1DFD · issued 2025 · renewal 2035
Assicurazione responsabilità professionale: AmTrust Europe · 5,000,000 EUR copertura · No claims on file

Procedure eseguite

ProceduraCodiceConteggio totale
GP consultation 99213 851
Annual physical exam 99395 413
Vaccination administration 90471 1,645
Minor procedure (skin) 17110 2,442

Servizi e prezzi

ServizioDurataModalitàPrezzo
New patient consultation (60m) 60 min in_clinic|telemed 180.00 EUR
Follow-up consultation (30m) 30 min in_clinic|telemed|phone 90.00 EUR
Vaccination administration 30 min in_clinic 540.00 EUR
Minor procedure (skin) 120 min in_clinic 810.00 EUR

Studio, team e in pratica

Amrita Mahal
HEADSHOT
Amrita Mahal in consultation
IN OFFICE
Amrita Mahal with the team
WITH TEAM
Amrita Mahal at a conference
CONFERENCE

Video

introduction · 90s
Meet Amrita Mahal

Ricerca e pubblicazioni

indice h: 14 · i10: 7

  1. Long-term follow-up of Speech And Language Therapy across GB
    Amrita Mahal, et al. · European Journal of Medicine, 2026
    DOI: 10.8090/euroclin.2026.0 · PMID: 31092290 · citato da 75
  2. Validation of clinical scoring in Speech And Language Therapy
    Amrita Mahal, et al. · European Journal of Medicine, 2025
    DOI: 10.3771/euroclin.2025.1 · PMID: 33229086 · citato da 33
  3. Long-term follow-up of Speech And Language Therapy across GB
    Amrita Mahal, et al. · European Journal of Medicine, 2024
    DOI: 10.8146/euroclin.2024.2 · PMID: 33850371 · citato da 111
  4. Validation of clinical scoring in Speech And Language Therapy
    Amrita Mahal, et al. · European Journal of Medicine, 2023
    DOI: 10.1786/euroclin.2023.3 · PMID: 34890613 · citato da 141

Conferenze su invito

  • Practical updates in Speech And Language Therapy European Annual Congress (Speech And Language Therapy) · Vienna · 2024 · invited
  • Single-centre experience in Speech And Language Therapy National Society Meeting · · 2023 · oral abstract

Premi e affiliazioni

Premi

  • 🏆 Top-rated Speech And Language Therapy — · EuroClinics Patient Choice · 2025 · regional

Iscrizioni a società

  • WONCA Europe — Family Doctors — Member · Dal 2025
  • national college of family doctors — Member · Dal 2025
  • European Union of Medical Specialists (UEMS) — Member · Dal 2025

Articoli di questo medico

  • Patient education Patient guide to Speech And Language Therapy
  • Awareness When should you see a speech and language therapy?

Per pazienti internazionali

Coordinatore
Patient liaison · amrita.mahal@euroclinics.example

Recensioni dei pazienti

Condividi la tua esperienza — aiuta altri pazienti a trovare il medico giusto. Scrivi una recensione →
20 – 4.000 caratteri

Gli invii sono moderati e possono richiedere 24-72 h per apparire pubblicamente. Non includere informazioni identificative del paziente.

Recensioni recenti

  • ★★★★★ ✓ Verificato
    Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
    Anna B.
  • ★★★★★ ✓ Verificato
    Took time to listen and reviewed all my previous results. I would absolutely recommend.
    Marco V.
  • ★★★★☆ ✓ Verificato
    Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
    Helena F.

Specialisti simili

Sfoglia tutti →